264 related articles for article (PubMed ID: 28132018)
21. Temporal changes in lung cancer: a 10-year study in a chest hospital.
Malignancy Study Group of Izmir Training and Research Hospital for Thoracic Medicine and Surgery (ITRHTMS)
Monaldi Arch Chest Dis; 2008 Dec; 69(4):157-63. PubMed ID: 19350837
[TBL] [Abstract][Full Text] [Related]
22. [Non small cell lung carcinoma in never-smokers at the Liege University Hospital : a retrospective cohort study, 2017-2018].
Debruche M; Mettlen C; Paulus A; Vaillant F; Sibille A; Frères P; Duysinx B; Louis R
Rev Med Liege; 2021 May; 76(5-6):446-451. PubMed ID: 34080378
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and survival in non-small cell lung cancer patients by smoking history: a population-based cohort study.
Löfling L; Karimi A; Sandin F; Bahmanyar S; Kieler H; Lambe M; Lamberg K; Wagenius G
Acta Oncol; 2019 Nov; 58(11):1618-1627. PubMed ID: 31373239
[No Abstract] [Full Text] [Related]
24. Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014.
Choi CM; Kim HC; Jung CY; Cho DG; Jeon JH; Lee JE; Ahn JS; Kim SJ; Kim Y; Choi YD; Suh YG; Kim JE; Lee B; Won YJ; Kim YC
Cancer Res Treat; 2019 Oct; 51(4):1400-1410. PubMed ID: 30913875
[TBL] [Abstract][Full Text] [Related]
25. Human papilloma virus in non-small cell lung cancer in never smokers: a systematic review of the literature.
Hasegawa Y; Ando M; Kubo A; Isa S; Yamamoto S; Tsujino K; Kurata T; Ou SH; Takada M; Kawaguchi T
Lung Cancer; 2014 Jan; 83(1):8-13. PubMed ID: 24252423
[TBL] [Abstract][Full Text] [Related]
26. Association Between Smoking History and Overall Survival in Patients Receiving Pembrolizumab for First-Line Treatment of Advanced Non-Small Cell Lung Cancer.
Popat S; Liu SV; Scheuer N; Gupta A; Hsu GG; Ramagopalan SV; Griesinger F; Subbiah V
JAMA Netw Open; 2022 May; 5(5):e2214046. PubMed ID: 35612853
[TBL] [Abstract][Full Text] [Related]
27. Differences between small-cell lung cancer and non-small-cell lung cancer among tobacco smokers.
Toh CK; Gao F; Lim WT; Leong SS; Fong KW; Yap SP; Hsu AA; Eng P; Koong HN; Thirugnanam A; Tan EH
Lung Cancer; 2007 May; 56(2):161-6. PubMed ID: 17270313
[TBL] [Abstract][Full Text] [Related]
28. The relevance of "Nonsmoking-associated lung cancer" in India: a single-centre experience.
Krishnamurthy A; Vijayalakshmi R; Gadigi V; Ranganathan R; Sagar TG
Indian J Cancer; 2012; 49(1):82-8. PubMed ID: 22842173
[TBL] [Abstract][Full Text] [Related]
29. Incidence trends and risk factors of lung cancer in never smokers: Pooled analyses of seven cohorts.
Rissanen E; Heikkinen S; Seppä K; Ryynänen H; Eriksson JG; Härkänen T; Jousilahti P; Knekt P; Koskinen S; Männistö S; Rahkonen O; Rissanen H; Malila N; Laaksonen MA; Pitkäniemi J;
Int J Cancer; 2021 Dec; 149(12):2010-2019. PubMed ID: 34398974
[TBL] [Abstract][Full Text] [Related]
30. Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status.
Kerrigan K; Wang X; Haaland B; Adamson B; Patel S; Puri S; Akerley W
Clin Lung Cancer; 2021 Jul; 22(4):260-267.e2. PubMed ID: 33678584
[TBL] [Abstract][Full Text] [Related]
31. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
[TBL] [Abstract][Full Text] [Related]
32. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
33. Clinical characteristics and survival in never smokers with lung cancer.
Parente Lamelas I; Abal Arca J; Blanco Cid N; Alves Pérez MT; Dacal Quintas R; Gómez Márquez H; García Montenegro RA; Marcos Velázquez P
Arch Bronconeumol; 2014 Feb; 50(2):62-6. PubMed ID: 24280242
[TBL] [Abstract][Full Text] [Related]
34. Smoking, Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424).
Cheng TD; Darke AK; Redman MW; Zirpoli GR; Davis W; Payne Ondracek R; Bshara W; Omilian AR; Kratzke R; Reid ME; Molina JR; Kolesar JM; Chen Y; MacRae RM; Moon J; Mack P; Gandara DR; Kelly K; Santella RM; Albain KS; Ambrosone CB
J Natl Cancer Inst; 2018 Jul; 110(7):734-742. PubMed ID: 29346580
[TBL] [Abstract][Full Text] [Related]
35. Smoking status during first-line immunotherapy and chemotherapy in NSCLC patients: A case-control matched analysis from a large multicenter study.
Cortellini A; De Giglio A; Cannita K; Cortinovis DL; Cornelissen R; Baldessari C; Giusti R; D'Argento E; Grossi F; Santoni M; Catino A; Berardi R; Sforza V; Rossi G; Antonuzzo L; Di Noia V; Signorelli D; Gelibter A; Occhipinti MA; Follador A; Rastelli F; Chiari R; Gravara LD; Inno A; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Filetti M; Montrone M; Citarella F; Pensieri MV; Russano M; Cantini L; Nigro O; Leonetti A; Bordi P; Minuti G; Landi L; De Toma A; Donisi C; Ricciardi S; Migliorino MR; Napoli VM; Leone G; Metro G; Banna GL; Friedlaender A; Addeo A; Ficorella C; Porzio G
Thorac Cancer; 2021 Mar; 12(6):880-889. PubMed ID: 33527756
[TBL] [Abstract][Full Text] [Related]
36. The incidence of venous thromboembolism among patients with primary lung cancer.
Chew HK; Davies AM; Wun T; Harvey D; Zhou H; White RH
J Thromb Haemost; 2008 Apr; 6(4):601-8. PubMed ID: 18208538
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of lung cancer in India: focus on the differences between non-smokers and smokers: a single-centre experience.
Noronha V; Dikshit R; Raut N; Joshi A; Pramesh CS; George K; Agarwal JP; Munshi A; Prabhash K
Indian J Cancer; 2012; 49(1):74-81. PubMed ID: 22842172
[TBL] [Abstract][Full Text] [Related]
38. Former smokers with non-small-cell lung cancers: a comprehensive investigation of clinicopathologic characteristics, oncogenic drivers, and prognosis.
Zheng S; Wang R; Zhang Y; Pan Y; Cheng C; Zheng D; Sun Y; Chen H
Cancer Med; 2016 Aug; 5(8):2117-25. PubMed ID: 27227356
[TBL] [Abstract][Full Text] [Related]
39. Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practice.
Yamaguchi N; Vanderlaan PA; Folch E; Boucher DH; Canepa HM; Kent MS; Gangadharan SP; Majid A; Kocher ON; Goldstein MA; Huberman MS; Costa DB
Lung Cancer; 2013 Oct; 82(1):31-7. PubMed ID: 23932486
[TBL] [Abstract][Full Text] [Related]
40. The prognostic impact of obstructive lung disease on survival of never smokers with resected non-small-cell lung cancer: a comparison with smokers.
Akamine T; Tagawa T; Shimokawa M; Matsubara T; Kozuma Y; Haratake N; Takamori S; Toyokawa G; Maehara Y
Interact Cardiovasc Thorac Surg; 2019 May; 28(5):735-743. PubMed ID: 30602039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
